Product to Relieve IUD Insertion Pain Enters Phase II

For women around the world who experience pain from the insertion of intrauterine devices (IUD), relief could soon be on the way. Stockholm-based pharmaceutical company Pharmanest AB announced the start of the randomized Phase II study of SHACT, a local anesthetic topically applied to the woman’s cervix and uterus. All patients in the initial Phase I study with SHACT are included in the double-blind, randomized, placebo-controlled Phase II study. The goal of Phase II is to evaluate the effect of SHACT in connection with IUD insertion in women. Pharmanest’s goal with SHACT is to achieve immediate pain relief without the need for advanced equipment.

Few New Treatments on Horizon for PTsD Sufferers

Despite growing numbers, members of the armed forces and victims of abuse taking medication for post-traumatic stress disorder (PTSD) are unlikely to see any major changes to their drug treatment in the near future, according to a new report by healthcare experts GlobalData. Only a few pharmaceutical companies are presently doing research into new or advanced treatment options for PTSD, creating a weak developmental pipeline.

Roche Cuts 1,000 Research Jobs

Roche closed its Pharma Research and Early Development unit in Nutley, NJ, which resulted in the loss of approximately 1,000 jobs. The company released a statement that said the site was being closed to streamline research activities and “support efficient allocation of resources for the group’s expanding product development pipeline.” The R&D responsibilities of the Nutley site will be consolidated in Basel and Schlieren, Switzerland and Penzberg, Germany.

New Mobile App Lets Reps Submit Info Via Smartphone

Healthcare representatives said they wanted a way to make submitting compliance documents easier and now, thanks to Vendormate, they’ve got it. The Atlanta-based company that works to connect healthcare providers with suppliers has advanced the nation’s first vendor-credentialing mobile app to allow representatives to photograph and send required documentation via their mobile devices. The app is free to any of Vendormate’s more than 200,000 healthcare suppliers with Android or Apple devices, including iPhone, iPod Touch and iPad. It is fully integrated with the previously released mobile app, which features hospital sign out, a database of healthcare locations and access to priority support from Vendormate.

Kantar Health And Sermo Enter Exclusive Partnership

Kantar Health, a consultant and marketing company, and Sermo, an online physician community, have formed a partnership to provide research services to life sciences companies. Kantar Health will access Sermo’s physician community to provide business insights and strategic recommendations to pharma/biotech, diagnostic and device companies. Sermo and Kantar Health’s collaboration began during the American Society of Clinical Oncology (ASCO) conference in Chicago.

ISPE releases New Volume in Pharmaceutical Change Management

The International Society for Pharmaceutical Engineering (ISPE) has released the latest volume in their Product Quality Lifecycle Implementation (PQLI) series, Change Management System as a Key Element of a Pharmaceutical Quality System. The Guide, which is Part 3 of the PQLI series, provides practical, real-world strategies that companies can use to implement the change management recommendations of ICH Q10. It is the only change management guide written expressly for the pharmaceutical industry.

Maureen Regan of RCW Honored with the Highest Leaf Award

Maureen Regan Honored With Highest Leaf Award
The Women’s Venture Fund 2012 Highest Leaf Awards presented Maureen Regan, Managing Partner of McCann Regan Campbell Ward, The Highest Leaf. The award is given to those whose contributions “impact their industry and exemplify the balance between outcome and responsibility in business decisions.” Under Regan’s leadership her com- pany, RCW, has won numerous awards, including MedAdNews Agency on the Rise in 2003 and MedAdNews Agency of the Year (Category II) in 2006.


You May Also Like

Avoid Choice Paralysis—Become the Default Option

Psychologist Barry Schwartz gives a great TED lecture on “The Paradox of Choice.”1 He ...

Next-Gen Gaming Unveiled

Pharma has dabbled in gaming as a way to improve adherence, but now the ...

Social Media: Time for Pharma to Suit Up and Show Up

Motivational speakers never tire of reminding us that the Chinese word for “crisis” is ...